We would like to thank all the volunteers who willingly participated in this study. We also thank members of the Yadava lab (WRAIR), Sattabongkot lab (AFRIMS), Pichyangkul lab (AFRIMS) and Malaria Serology lab (WRAIR) for technical assistance as well as the staff of the WRAIR Clinical Trials Center and Human Subjects Protection Branch for their assistance in the conduct and reviewing stages of this study. Thanks are also due to the research monitor COL Mark Kortepeter, and project coordinators, in particular, April Kathcart (WRAIR), Danielle Morelle (GSK) and Alicja Brown (PATH-MVI) for their valuable assistance during the course of this study.

Disclaimer
The authors with affiliations 1–5 are, or were at the time the study was conducted, employees of the United States Government. This work was prepared as part of their official duties. Title 17 U.S.C. §105 provides that ‘Copyright protection under this title is not available for any work of the United States Government.’ Title 17 U.S.C. §101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person’s official duties.
The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Army, the Department of the Navy, the Department of Defense, nor the U.S. Government.


Previous presentation
This data was presented, in part, at the 60th Annual meeting of the American Society of Tropical Medicine and Hygeine (December 4–8, 2011) in Philadelphia,